Inventor

Elyse Marie Josee Bourque

Inventor
L'etang-Du-Nord, CA

Overview

20→
Patents
2016–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides8%
H10KOrganic electric solid-state devices4%
H10WGeneric packages, interconnections, connectors or other constructional details of devices covered by class h104%
Y02ATechnologies for adaptation to climate change4%
C07CAcyclic or carbocyclic compounds3%
C12NMicroorganisms or enzymes3%
PatentTitleYear
11,124,516Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders202111,091,492Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders202111,084,796Heterocyclic derivatives for the treatment of RSV202110,988,465CXCR4 inhibitors and uses thereof202110,934,298Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders202110,906,899Bicyclic fused pyrazole derivatives for the treatment of RSV202110,787,454Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders202010,786,508Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders202010,759,796CXCR4 inhibitors and uses thereof202010,751,341Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders202010,675,355VAR2CSA-drug conjugates202010,570,135Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders202010,450,378Cytotoxic and anti-mitotic compounds, and methods of using the same201910,414,822Cytotoxic and anti-mitotic compounds, and methods of using the same201910,201,614Cytotoxic and anti-mitotic compounds, and methods of using the same20199,920,061'Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders'20189,879,086'Cytotoxic and anti-mitotic compounds, and methods of using the same'20189,868,742'Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disorders'20189,840,510'Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders'20179,522,876'Cytotoxic and anti-mitotic compounds, and methods of using the same'2016

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2016–2020Patents assigned to ZYMEWORKS INC (6)· patent assignee history
2016–2019Based in Blaine, WA, US· patent location history
2017–2020Patents assigned to LYSOSOMAL THERAPEUTICS INC (6)· patent assignee history
2017–2021Based in L'etang-Du-Nord, CA· patent location history
2020–2021Patents assigned to BIAL—BIOTECH INVEST INC (3)· patent assignee history
2020–2021Patents assigned to BIAL BIOTECH INVEST INC (2)· patent assignee history
2020–2021Based in Bellingham, WA, US· patent location history
2020Based in Montréal-Nord, CA· patent location history
2021Patents assigned to UNIV GEORGIA STATE RES FOUND (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LYSOSOMAL THERAPEUTICS INC62017–2020
ZYMEWORKS INC62016–2020
BIAL—BIOTECH INVEST INC32020–2021
BIAL BIOTECH INVEST INC22020–2021
UNIV GEORGIA STATE RES FOUND22021
Locations
LocationPatentsSpan
L'etang-Du-Nord, CA152017–2021
Bellingham, Washington, US22020–2021
Blaine, Washington, US22016–2019
Montréal-Nord, CA12020